Reconstruction of cell-specific models capturing the influence of metabolism on DNA methylation in cancer

Tânia Barata1, Vítor Pereira2, Ricardo Pires das Neves3

  • 1CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-517 Coimbra, Portugal.

PubMed

Insights

Cancer cell metabolism influences DNA methylation, impacting gene expression and cancer development. This study models this link to identify new epigenetic therapy targets.

Area of Science:

  • Biochemistry
  • Systems Biology
  • Cancer Biology

Background:

  • Epigenetic deregulation, particularly DNA methylation imbalances, contributes to cancer by altering gene expression.
  • Cancer cell metabolic reprogramming affects metabolite availability, influencing epigenetic regulators and promoting cancer progression.
  • Understanding the interplay between cancer metabolism and DNA methylation is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the influence of cancer metabolic reprogramming on DNA methylation.
  • To develop predictive models linking metabolic shifts to DNA methylation patterns in cancer.
  • To identify potential therapeutic targets for cancer epigenetic therapy.

Main Methods:

  • Reconstruction of Genome-Scale Metabolic Models (GSMMs) for 31 cancer cell lines, incorporating DNA methylation/demethylation reactions.
  • Integration of enzymatic constraints using Kinetic and Omics data (GECKOs) into the GSMMs.
  • Inclusion of cell-line-specific DNA methylation levels to model metabolic influence on global DNA methylation.

Main Results:

  • Validated GSMMs accurately predicted experimental metabolic exchange rates and functional cell behavior.
  • Identified specific metabolic pathways, reactions, and enzymes associated with gene promoter methylation.
  • Discovered two promising candidate targets for epigenetic cancer therapy.

Conclusions:

  • Metabolic reprogramming significantly influences DNA methylation in cancer cells.
  • The developed models provide a powerful tool for studying cancer metabolism-epigenetics interactions.
  • This research opens avenues for targeted epigenetic therapies based on metabolic vulnerabilities.